All Insights
Showing 193 - 204 of 400
Regulatory and compliance
The next milestone approaches in the UK NHS net zero supplier roadmap
From April 2024, the NHS will proportionately extend the requirement for suppliers to prepare Carbon Reduction Plans to all procurements
Life Sciences and Healthcare
Using health data for R&D and AI: will new legislation make this possible in Germany?
The new health-data bill currently debated by the German lawmakers could be adopted this year and apply from early 2024
Life Sciences and Healthcare
Digital therapeutics in Europe: what is the state of play?
The regulatory landscape varies, but the potential for the sector is immense
IT and data
How the European Court of Justice is shaping health data anonymisation
A recent ruling gives valuable legal guidance on personal data but what are the practical implications for healthcare?
Life Sciences and Healthcare
Sunshine Act: introducing a transparent healthcare system
Law no. 62 of 3 May 2022, "Provisions on the transparency of relations between companies, professionals operating in the health
Life Sciences and Healthcare
EU's 'flexible' pharma reforms likely to require fine-tuning to address uncertainties
The reduction of the regulatory data protection period and wholesale distribution changes raise some industry concern
Life Sciences and Healthcare
EU to reform rules for drug-device combinations, product information and pharmacovigilance
The proposal's eight-week consultation has allowed the sector to assess the draft legislation in these and other areas
Life Sciences and Healthcare
EU pharmaceutical reforms to overhaul marketing and manufacturing rules
A dvertising, marketing authorisation applications and imports are among the areas targeted by the draft proposals
Life Sciences and Healthcare
Polish reimbursement law changes
A bill to amend the Act on the Reimbursement of Medicines and Certain Other Acts ('the Reimbursement Bill') is pending
Artificial intelligence
What risks need to be considered by a UK business using artificial intelligence?
An overview of the legal and regulatory risks arising from AI deployment published in our article in Compliance & Risk
Regulatory and compliance
UK government heralds 'indefinite' CE marking recognition in GB market
Businesses will still need to look carefully at regulations and determine if a UKCA or CE mark is more appropriate
Digitalisation
Neurotechnology advances pose discriminatory and privacy risks, warns the UK's ICO
The global brain-monitoring technology market could be worth $17.1bn by 2026 but will bring ethical and legal challenges
